Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GliomaAI-Astro4: Non-Invasive MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 Using Artificial Intelligence

NCT07673679 is registered in ClinicalTrials.gov with Deep Learning Institute of Radiological Sciences as lead sponsor.

NCT NCT07673679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07673679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GliomaAI-Astro4: Non-Invasive MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 Using Artificial Intelligence
Lead sponsor
Deep Learning Institute of Radiological Sciences
Phase
Observational
Overall status
Completed
Start date
March 14, 2017
Completion date
June 16, 2021
Enrollment
1,372 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, astrocytoma, grade iv, astrocytoma, idh-mutant, grade 4, glioma, glioma (diagnosis)